NCT02546232View on ClinicalTrials.gov

Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

196

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2028

Conditions

Breast Cancer

Interventions

DRUG

Carboplatin

Chemotherapy

DRUG

Paclitaxel

Chemotherapy

Trial Locations (1)

Unknown

Oslo University Hospital, Oslo

All Listed Sponsors

lead

Oslo University Hospital

OTHER